Scancell utilises nanotechnology to amp up solid tumour vaccine
Scancell and Cancer Research UK use nanodelivery technology to activate the body’s immune system, boosting its ability to target and destroy cancer cells.
Scancell and Cancer Research UK use nanodelivery technology to activate the body’s immune system, boosting its ability to target and destroy cancer cells.
US FDA issues Lupin with a Form 483 based on three observations during a recent inspection at its Aurangabad site.
Navitas has acquired KAI Research to expand its trial site footprint in North America and Africa as well as bolster its ability to manage clinical trials in a number of research areas.
Advarra will provide IRB services to the Institute for Advanced Clinical Trials for Children’s pediatric clinical trial site network.
Verily is aligning itself with big names in pharma to bolster its Project Baseline, designed to use digital sources to promote patient-centered clinical research programs.